Well it looks as though Christmas has come early for out friends at Bigfoot as they have secured an additional $37 million in funding. This is obviously great news for Bigfoot and not so good news for our friends at Tandem (NASDAQ: TNDM). Think about this just for a moment Bigfoot has a great idea some nice relationships but nothing on the market yet. Tandem has almost 60,000 patients a real insulin pump a ready made infrastructure but they can’t raise a dime.
One just might think by now people would start to realize that the clock is . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.